Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database

OBJECTIVES: The survival advantage of radiotherapy (RT) for patients with stage IV non‐small cell lung cancer (NSCLC) has not been adequately evaluated. METHODS: We analyzed stage IV NSCLC patients enrolled from the Surveillance, Epidemiology, and End Results (SEER) registry through January 2010 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Rui, Li, Ping, Li, Qin, Qiao, Yunfeng, Xu, Tangpeng, Ruan, Peng, Song, Qibin, Fu, Zhenming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198236/
https://www.ncbi.nlm.nih.gov/pubmed/30239162
http://dx.doi.org/10.1002/cam4.1776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198236/
https://www.ncbi.nlm.nih.gov/pubmed/30239162
http://dx.doi.org/10.1002/cam4.1776

Ejemplares similares